Generate a tailored SOP for Dr. Mingu Kang. Improve your application with a focused, well-structured draft.
Mingu Kang is a Postdoctoral Scholar in the Department of Pharmacology at the University of Washington. His research focuses on Cancer Biology, specifically the oncogenic role of DNAJ-PKAc, a significant driver of fibrolamellar carcinoma (FLC). He investigates the genetic alterations in FLC patients, particularly the heterogeneous deletion that produces the pathogenic fusion kinase DNAJ-PKAc. His work aims to study the downstream signaling pathways of DNAJ-PKAc, with a particular emphasis on the newly identified interactions with molecular chaperones, such as Hsp70 and BAG2. Kang's efforts are directed towards uncovering novel therapeutic strategies for fibrolamellar carcinoma, contributing valuable insights into cancer signaling and potential treatment avenues.
Standard Graduate School requirements for University of Washington apply to most departments listed unless specified otherwise by the program.